Breakout
Date & Time:
March 25, 2025
12:00 PM – 1:30 PM ET
Format:
In Person & Virtual
CE Credits:
1.5 Hours
UAN: JA0002345-0000-25-066-L99-P
Course level:
Intermediate
Pediatric Content
session objectives:
What You'll Learn
LEARNING OBJECTIVES
- Describe initiation, advancement, and goals of parenteral nutrition for preterm infants with attention to addressing the challenges of neonatal refeeding syndrome.
- Optimize calcium and phosphorus provision in parenteral nutrition to prevent metabolic bone disease.
- Illustrate the challenges of maximizing calcium and phosphorus provision given the limitations of neonatal parenteral nutrition formulations.
- Discuss the advantages and disadvantages of the various lipid injectable emulsion formulations utilized in the preterm population.
This session will be reviewed for BCNSP-approved recertification credit through Purdue University College of Pharmacy
Topics & Presenters
Optimizing Early Parenteral Nutrition in Preterm Infants: Achieving Goals and Safeguarding Against Neonatal Refeeding Syndrome
Stephanie Merlino Barr
PhD, RDN, LD
Neonatal Dietitian
Neonatal Intensive Care Unit, MetroHealth
Cleveland, OH
Optimizing Bone Mineral Provision in Parenteral Nutrition Strategies for Preventing Metabolic Bone Disease in Preterm Infants
Andrew Calabria
MD
Pediatric Endocrinologist and Clinical Director
Division of Endocrinology and Diabetes, Children’s Hospital of Philadelphia
Philadelphia, PA
Optimizing Parenteral Nutrition for Preterm Infants: Challenges of Calcium, Phosphorus, and Lipid Injectable Emulsion Provision
M. Petrea Cober
PharmD, BCNSP, BCPPS, FASPEN
Professor of Pharmacy Practice
Northeast Ohio Medical University, College of Pharmacy
Director of Professional Development
Office of Education, Northeast Ohio Medical University, College of Pharmacy
Rootstown, OH
Moderators:
Molly Potter
MS, RD, CSP, LDN, CNSCSenior Clinical Dietitian III, Formula and Human Milk Clinical Lead
Nemours Children's Hospital, Delaware
Wilmington, DE